Related Experiment Video
Updated: Jun 16, 2025

A Method to Estimate Cadaveric Femur Cortical Strains During Fracture Testing Using Digital Image Correlation
Published on: September 14, 2017
Rethinking Lafontaine Criteria: Second Metacarpal Cortical Percentage as a Reliable Predictor of Distal Radius
Clinton J Ulmer1, Luke Verlinsky1, Chimobi C Emukah1
1The University of Texas Health Science Center at San Antonio, USA.
Background:
Distal radius fractures represent a significant cause of morbidity and loss of independence, particularly in older patients. There is no good consensus on which fractures managed nonoperatively will be unstable in a cast or splint other than Lafontaine criteria, the only relevant clinical study to date. Second metacarpal cortical percentage (2MCP) has been shown to be a reliable predictor of osteoporosis and poor bone quality. This study investigates the utility of 2MCP as an independent predictor of fracture displacement in nonoperative fracture management.
Methods:
A retrospective cohort of distal radius fractures treated conservatively over 7 years (2013-2020) was investigated. Injury, postreduction, and 4-week follow-up radiographs were reviewed for 2MCP, volar tilt, ulnar variance, and other demographic factors. Multivariate regression analysis was used to predict fracture displacement.
Results:
Only 2MCP and initial fracture displacement were associated with displacement at 4 weeks (P = .008, P = .008). Other than initial fracture displacement, Lafontaine criteria were not associated with radiographic outcomes. A 2MCP threshold of 53.5% optimized sensitivity (67.5%) and specificity (70.2%) in predicting 10° of fracture displacement (P = .003). A 2MCP threshold of 49.5% was 86.7% sensitive and 74.7% specific at detecting dorsal malunion (P = .032).
Conclusions:
Second metacarpal cortical percentage is a useful clinical tool in predicting distal radius fracture instability. Clinicians can use 2MCP both in guiding decision-making when selecting patients who may benefit from operative management and as a screening tool for osteoporosis and initiation of antiresorptive therapy.

